Efficiency and safety of autologous chimeric antigen receptor T-cells therapy used for patients with lymphoma: A systematic review and meta-analysis

BACKGROUND: Chimeric antigen receptor (CAR) T-cell therapy has produced promising response rates in patients with B cell malignancies. However, previous meta-analyses have demonstrated that CAR T-cell efficacy is unsatisfactory in patients with lymphoma unlike in patient with other hematological mal...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Genmao, Lei, Lijian, Zhu, Xiaolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824817/
https://www.ncbi.nlm.nih.gov/pubmed/31626107
http://dx.doi.org/10.1097/MD.0000000000017506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824817/
https://www.ncbi.nlm.nih.gov/pubmed/31626107
http://dx.doi.org/10.1097/MD.0000000000017506

Ejemplares similares